Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

T cell clones shrink melanoma tumors

13.11.2002


Paper published in the Proceeding of the National Academy of Sciences



Below is an advisory distributed today by the Proceedings of the National Academy of Sciences (PNAS). The paper can be found in the online early edition of PNAS at www.pnas.org.

The study, conducted by Dr. Cassian Yee, a researcher at the Fred Hutchinson Cancer Research Center, involved 10 people diagnosed with advanced melanoma. For each patient immune system cells able to identify and target melanoma were extracted and cloned. The cloned cells were expanded in the lab and re-injected into the patient. The results of the study showed that in five patients tumors stopped growing for up to one year and in three of the patients the tumors appeared to shrink.


"While we did not expect to cure the cancers, the technique appears to benefit patients by curbing the spread of their tumors, says Dr. Yee."

Soldier Clones: T Cells Target Tumors

A preliminary clinical trial suggests that armies of T cells generated in the lab can be injected into patients to halt the spread of cancerous tumors. One strategy for treating cancer is to sensitize the immune system to the presence of tumors so it can attack the cancerous cells. Vaccinating patients with proteins present on the cancerous cells could kick the immune system into action. Instead of relying on the immune system to manufacture a defense, however, Cassian Yee and colleagues tried supplying ready-made soldiers. In the lab, the authors grew T cells, those cells that destroy invaders or aberrant cells. To insure that the T cells found their target, the authors trained them on their quarry, stimulating the cells with a protein found on metastatic melanoma cells. The authors then injected these designer T cells into 10 patients over the course of 12 weeks. The results, reported in article #6000, indicate that the T cells clones were able to home in on the tumors, which regressed slightly or stabilized in 8 of the 10 patients, for an average period of 11 months. In addition to T cells, the injections contained IL-2, a chemical that stimulates the T cells to replicate, resupplying the troops. Although IL-2 can be toxic in high doses, the patients showed little reaction to the low dose of IL-2 used.


"Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastic melanoma: in vivo persistence, migration and anti-tumor effect of transferred T cells" by C. Yee, J.A. Thompson, D. Byrd, S.R. Riddell, P. Roche, E. Celis, P.D. Greenberg.

Susan Edmonds | EurekAlert!
Further information:
http://www.fhcrc.org/
http://www.pnas.org/

More articles from Health and Medicine:

nachricht Hot cars can hit deadly temperatures in as little as one hour
24.05.2018 | Arizona State University

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>